PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTiopronin
Tiopronin
Thiola, Tiopronin (tiopronin) is a small molecule pharmaceutical. Tiopronin was first approved as Thiola on 1988-08-11.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Thiola, Tiopronin (discontinued: Tiopronin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Tiopronin
Tradename
Company
Number
Date
Products
THIOLAMission PharmacalN-019569 RX1988-08-11
1 products, RLD, RS
THIOLA ECMission PharmacalN-211843 RX2019-06-28
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
thiolaNew Drug Application2024-01-08
thiola ecNew Drug Application2024-01-08
tioproninANDA2024-11-01
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
TIOPRONIN, THIOLA, MISSION PHARMA
2026-06-28ODE-267
TIOPRONIN, THIOLA EC, MISSION PHARMACAL
2026-06-28ODE*
Patent Expiration
Patent
Expires
Flag
FDA Information
Tiopronin, Thiola Ec, Mission Pharmacal
114581042038-11-14U-3441
ATC Codes
G: Genito urinary system and sex hormones
— G04: Urologicals
— G04B: Urologicals
— G04BX: Other urologicals in atc
— G04BX16: Tiopronin
HCPCS
No data
Clinical
Clinical Trials
6 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CystinuriaD003555—E72.01—1—124
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wounds and injuriesD014947—T14.8—1———1
Chemical and drug induced liver injuryD056486EFO_0004228——1———1
HemorrhageD006470MP_0001914R58—1———1
Subarachnoid hemorrhageD013345EFO_0000713I60—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTiopronin
INNtiopronin
Description
Tiopronin is a N-acyl-amino acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(S)C(=O)NCC(=O)O
Identifiers
PDB—
CAS-ID1953-02-2
RxCUI—
ChEMBL IDCHEMBL1314
ChEBI ID32229
PubChem CID5483
DrugBankDB06823
UNII IDC5W04GO61S (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Tiopronin – Travere Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Tiopronin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 807 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,770 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use